Floatz logo

Pri-724

Liver Cirrhoses

Kiminori Kimura, MDPhase 2Active
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

142 Active assets in the Liver Cirrhoses cohort.

Asset / SponsorPhaseRating
PARITAPREVIR
AbbVie
Phase 3A
GLY-GLY-GLY-CYS-TYR-PHE-GLN-ASN-CYS-PRO-LYS-GLY-NH2 (4-9 DISULFIDE)
General Hospital of Shenyang Military Region
Phase 4BBB
Tolvaptan
Institute of Liver and Biliary Sciences, India
Phase 4BBB
CHOLYL-LYSL-FLUORESCEIN
Norgine
Phase 3BBB
NORMAL HUMAN SERUM ALBUMIN
King George's Medical University
Phase 4BBB

View all 50 →

Same molecule, other indications

Pri-724 is also rated in:

colorectal cancerDormant
CCC
Indicative ·
53 / 100
View asset →
hepatitis C virus infectionDormant
CCC
Indicative ·
52 / 100
View asset →
colorectal adenocarcinomaDormant
CCC
Indicative ·
51 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →